Přihlásit se Zaregistrujte se zdarma

SMA 50 společnosti Starpharma

Jaká je hodnota metriky SMA 50 společnosti Starpharma?

Hodnota metriky SMA 50 společnosti Starpharma Holdings Limited je AUD$0 -1.63%

Jaká je definice metriky SMA 50?



SMA 50 je průměrná cena akcií z posledních 50 dnů vypočítaná jako nevážený průměr předchozích 50 závěrečných cen.

Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.

Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.

SMA 50 společností v sektoru Health Care sektor na ASX ve srovnání se společností Starpharma

Čemu se věnuje společnost Starpharma?

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Firmy s metrikou sma 50 podobnou společnosti Starpharma



  • Hodnota metriky SMA 50 společnosti Goldhills je CAD$0 -34.10%
  • Hodnota metriky SMA 50 společnosti Graphene 3D Lab je CAD$0 -88.00%
  • Hodnota metriky SMA 50 společnosti Aeeris je AUD$0 -52.07%
  • Hodnota metriky SMA 50 společnosti China Properties Investment je HKD$0 -8.48%
  • Hodnota metriky SMA 50 společnosti Wealth Minerals je CAD$0 +10.10%
  • Hodnota metriky SMA 50 společnosti CML je $0 -22.61%
  • Hodnota metriky SMA 50 společnosti Starpharma je AUD$0 -1.63%
  • Hodnota metriky SMA 50 společnosti BeMetals je CAD$0 -26.22%
  • Hodnota metriky SMA 50 společnosti Core Lithium Ltd je AUD$0 +5.19%
  • Hodnota metriky SMA 50 společnosti Forum Metals je CAD$0 -11.59%
  • Hodnota metriky SMA 50 společnosti Bitcoin Well Inc je CAD$0 +5.00%
  • Hodnota metriky SMA 50 společnosti Harfang Exploration je CAD$0 -46.15%
  • Hodnota metriky SMA 50 společnosti Aquarius AI je CAD$0 +20.83%